Results 81 to 90 of about 3,285,062 (216)
Background: An epileptic seizure was defined as a transient occurrence of signs and symptoms due to abnormal excessive neuronal activity in the brain. A seizure lasting 30 minutes or longer or a series of seizures in which the patient did not regain
Zainab Adel Omran, Ahmed Hamed Jwied
doaj +1 more source
Abstract Progressive familial intrahepatic cholestasis type 1 (PFIC1), caused by ATP8B1 deficiency, is a multisystem disorder with extrahepatic manifestations; however, renal involvement has rarely been described. We report a child with genetically confirmed PFIC1 who underwent living donor liver transplantation (LT) for progressive liver disease ...
Angela Marino +3 more
wiley +1 more source
Is ursodeoxycholic acid crucial for ischemia/reperfusion-induced ovarian injury in rat ovary?
Purpose: Ursodeoxycholic acid is frequently used in cholestatic liver diseases. Also, it protects hepatocytes against oxidative stress induced by hydrophobic bile acids.
Akdemir A. +9 more
core +2 more sources
Chronic kidney disease‐associated pruritus (CKDaP) is a frequent complication of advanced CKD with an incompletely understood pathophysiology. We identified a significantly altered glycine‐to‐taurine conjugated bile acid ratio in patients with CKDaP despite unchanged total serum bile acid concentrations.
Miriam M. Düll +6 more
wiley +1 more source
Separation of the glycine and taurine conjugates of ursodeoxycholic acid from those of lithocholic acid, chenodeoxycholic acid, deoxycholic acid, and cholic acid by thin-layer chromatography is described.
A K Batta, S Shefer, G Salen
doaj +1 more source
Quality of life in patients with biliary tract diseases taking UDCAcontaining drug
Background. When bile is oversaturated with cholesterol, the dynamic equilibrium between proand antinucleating factors is disturbed, which leads to precipitation of cholesterol crystals and their aggregation into microlites.
A. M. Lukmanova +2 more
doaj +1 more source
Abstract Background Ursodeoxycholic acid (UDCA) has shown mitochondrial and neuroprotective effects and has been proposed as a treatment for Parkinson's disease (PD). However, population‐level evidence on its effect on PD risk is lacking. Objectives To compare the risk of incident PD among UDCA initiators versus matched non‐initiators within a ...
Chengsheng Ju +7 more
wiley +1 more source
The effectiveness of ursodeoxycholic acid in treating biliary liver diseases is limited by low bioavailability and moderate activity. A new analogue of ursodeoxycholic acid was synthesized with a fluorine atom in position 6 because this should have ...
A. Roda +8 more
core +1 more source
Recompensation of Cirrhosis: A New Treatment‐Related Disease State
This perspective article conceptualizes recompensation of cirrhosis as a distinct treatment‐related disease state rather than mere transient clinical improvement after etiology‐directed therapy, and further proposes a four‐state classification including compensated cirrhosis, stable recompensation, unstable recompensation, and persistent decompensation
Wentao Tan +5 more
wiley +1 more source
Use of Ursodeoxycholic Acid for the Treatment of Biliary Dysfunction in Children
The article discusses the positive experience of using Ukrliv containing ursodeoxycholic acid in children with functional biliary ...
N.B. Sapa, T.V. Yaroshevskaya
core +1 more source

